Which drug is best for pulmonary hypertensive crisis? new trial aims to find out
NCT ID NCT07667829
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial will compare three drugs—dopamine, norepinephrine, and epinephrine—to see which works best for people experiencing a pulmonary hypertensive crisis, a life-threatening spike in blood pressure in the lungs. The study will enroll 75 adults with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension who are hospitalized. The main goal is to see which drug reduces the risk of death within 28 days, while also monitoring side effects like irregular heartbeats.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dopamine, norepinephrine, and epinephrine
What this could lead to
If this trial succeeds, it could identify the safest and most effective vasopressor for managing pulmonary hypertensive crisis, potentially improving survival and reducing complications.
What could go wrong
This is a small, early-stage trial (75 participants) comparing existing drugs, so results may not be definitive. The study is not yet recruiting, and outcomes may not apply to all patients with pulmonary hypertension.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION, PULMONARY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese Academy of Medical Sciences, Fuwai Hospital
Beijing, Beijing Municipality, 10037, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510180, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhongnan Hospital of Wuhan University
Wuhan, Wuhan, 430072, China
Contact Phone: •••-•••-•••• Email: •••••@•••••